Before being placed on the market, each batch of vaccines is:
- analysed in the laboratory and
- the quality assurance documentation provided by producers is independently reviewed and evaluated.
In Belgium, Sciensano certifies the quality of vaccines made available to the population, as the officially recognised national laboratory for the control of biological medicinal products (i.e. vaccines and all plasma-derived products) by the Belgian health authorities. As an internationally recognised expert part of the European Official Medicine Control Laboratory (OMCL) Network, Sciensano controls about 30% of all vaccines marketed in Europe.
Geneviève Waeterloos for more information about the control procedure and how to request permission to sell your vaccine batch on the Belgian and European market.